Introduction: Oral cytopathology is able to detect incipient cellular alterations, but it is not routinely applied to this purpose. We aimed to establish a model to screen individuals with no oral lesion exposed to smoking/alcohol, by means of the nuclear area, cell proliferation rate, and analysis of genetic damage. Methods: In this cross-sectional pilot study, 90 patients were allocated into 3 groups: oral cancer group (patients with oral squamous cell carcinoma), tobacco/alcohol group (patients without oral lesions and exposed to these risk factors), and control group (individuals with no lesion and not exposed to tobacco and alcohol). The cytological smears performed in these individuals were stained with Papanicolaou, a silver-staining and a Feulgen reaction. The nuclei of cells were measured, and AgNORs/nucleus and micronuclei (MN) were quantified. The cutoff values were stipulated evaluating the healthy mucosa (control group) and the cancerization field mucosa (oral cancer group). Results: Cutoff values for the screening of individuals exposed to carcinogens were ≥8% of nuclei larger than 100 μm2, ≥3.38 AgNOR/nucleus, and ≥3 MN per 1,000 cells. Conclusions: Nuclear area measurement and AgNORs/nucleus and MN quantification identified the incipient phase of oral carcinogenesis. A screening model for individuals without oral lesion exposed to smoking/alcohol was proposed.

1.
Losi-Guembarovski
R
,
Menezes
RP
,
Poliseli
F
,
Chaves
VN
,
Kuasne
H
,
Leichsenring
A
,
Oral carcinoma epidemiology in Paraná State, Southern Brazil
.
Cad Saude Publica
.
2009 Feb
;
25
(
2
):
393
400
. .
2.
Zavras
A
,
Andreopoulos
N
,
Katsikeris
N
,
Zavras
D
,
Cartsos
V
,
Vamvakidis
A
.
Oral cancer treatment costs in Greece and the effect of advanced disease
.
BMC Public Health
.
2002 Jul
;
2
:
12
. .
3.
Sugerman
PB
,
Savage
NW
.
Exfoliative cytology in clinical oral pathology
.
Aust Dent J
.
1996 Apr
;
41
(
2
):
71
4
. .
4.
Khot
K
,
Deshmane
S
,
Bagri-Manjarekar
K
,
Warke
D
,
Kotak
K
.
A cytomorphometric analysis of oral mucosal changes in tobacco users
.
J Nat Sci Biol Med
.
2015 Aug
;
6
(
Suppl 1
):
S22
4
. .
5.
Derenzini
M
,
Trerè
D
,
Pession
A
,
Montanaro
L
,
Sirri
V
,
Ochs
RL
.
Nucleolar function and size in cancer cells
.
Am J Pathol
.
1998 May
;
152
(
5
):
1291
7
.
6.
Gedoz
L
,
Lauxen Ida
S
,
Sant’Ana
MF
,
Rados
PV
.
Proliferative activity in clinically healthy oral mucosa exposed to tobacco smoking and alcohol: a longitudinal study using the agNOR staining technique
.
Anal Quant Cytol Histol
.
2007 Aug
;
29
(
4
):
231
8
.
7.
Fenech
M
.
The in vitro micronucleus technique
.
Mutat Res
.
2000 Nov
;
455
(
1–2
):
81
95
. .
8.
Bonassi
S
,
Coskun
E
,
Ceppi
M
,
Lando
C
,
Bolognesi
C
,
Burgaz
S
,
The human micronucleus project on exfoliated buccal cells (HUMN[XL]): the role of life-style, host factors, occupational exposures, health status, and assay protocol
.
Mutat Res
.
2011 Nov–Dec
;
728
(
3
):
88
97
. .
9.
Tolbert
PE
,
Shy
CM
,
Allen
JW
.
Micronuclei and other nuclear anomalies in buccal smears: methods development
.
Mutat Res
.
1992 Feb
;
271
(
1
):
69
77
. .
10.
Nersesyan
A
,
Muradyan
R
,
Kundi
M
,
Knasmueller
S
.
Impact of smoking on the frequencies of micronuclei and other nuclear abnormalities in exfoliated oral cells: a comparative study with different cigarette types
.
Mutagenesis
.
2011 Mar
;
26
(
2
):
295
301
. .
11.
Bohrer
PL
,
Filho
MS
,
Paiva
RL
,
da Silva
IL
,
Rados
PV
.
Assessment of micronucleus frequency in normal oral mucosa of patients exposed to carcinogens
.
Acta Cytol
.
2005 May–Jun
;
49
(
3
):
265
72
. .
12.
Braakhuis
BJ
,
Leemans
CR
,
Brakenhoff
RH
.
A genetic progression model of oral cancer: current evidence and clinical implications
.
J Oral Pathol Med
.
2004 Jul
;
33
(
6
):
317
22
. .
13.
Seifi
S
,
Feizi
F
,
Mehdizadeh
M
,
Khafri
S
,
Ahmadi
B
.
Evaluation of cytological alterations of oral mucosa in smokers and waterpipe users
.
Cell J
.
2014
;
15
(
4
):
302
9
.
14.
Jindal
S
,
Chauhan
I
,
Grewal
HK
.
Alteration in buccal mucosal cells due to the effect of tobacco and alcohol by assessing the silver-stained nucleolar organiser regions and micronuclei
.
J Cytol
.
2013 Jul
;
30
(
3
):
174
8
. .
15.
ClinCalc.com [Internet]. Sample size calculator [cited 2016 Aug 28]. Available from: https://clincalc.com/stats/samplesize.aspx.
16.
Thomas
DC
.
Invited commentary: is it time to retire the “pack-years” variable? Maybe not!
Am J Epidemiol
.
2014 Feb
;
179
(
3
):
299
302
. .
17.
Ploton
D
,
Menager
M
,
Jeannesson
P
,
Himber
G
,
Pigeon
F
,
Adnet
JJ
.
Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level
.
Histochem J
.
1986 Jan
;
18
(
1
):
5
14
. .
18.
Thomas
P
,
Holland
N
,
Bolognesi
C
,
Kirsch-Volders
M
,
Bonassi
S
,
Zeiger
E
,
Buccal micronucleus cytome assay
.
Nat Protoc
.
2009
;
4
(
6
):
825
37
. .
19.
Crocker
J
,
Boldy
DA
,
Egan
MJ
.
How should we count AgNORS? Proposals for a standardized approach
.
J Pathol
.
1989 Jul
;
158
(
3
):
185
8
. .
20.
Warnakulasuriya
S
,
Reibel
J
,
Bouquot
J
,
Dabelsteen
E
.
Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement
.
J Oral Pathol Med
.
2008 Mar
;
37
(
3
):
127
33
. .
21.
Centers for Disease Control and Prevention (CDC)
.
National Center for Health Statistics. Glossary ‒ Alcohol
.
Centers for Disease Control and Prevention
;
2020
. Available from: www.cdc.gov/nchs/nhis/alcohol/alcohol_glossary.htm Accessed 2020 Mar.
22.
Centers for Disease Control and Prevention (CDC)
.
[Internet]. National Center for Health Statistics. Glossary. General Concepts
.
Centers for Disease Control and Prevention
;
2020
[cited 2020 Mar 1]. Available from: www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm.
23.
Dolens Eda
S
,
Nakai
FV
,
Santos Parizi
JL
,
Alborghetti Nai
G
.
Cytopathology: a useful technique for diagnosing oral lesions?A systematic literature review
.
Diagn Cytopathol
.
2013 Jun
;
41
(
6
):
505
14
.
24.
Abdullah
AS
,
Husten
CG
.
Promotion of smoking cessation in developing countries: a framework for urgent public health interventions
.
Thorax
.
2004 Jul
;
59
(
7
):
623
30
. .
25.
Weigum
SE
,
Floriano
PN
,
Redding
SW
,
Yeh
CK
,
Westbrook
SD
,
McGuff
HS
,
Nano-bio-chip sensor platform for examination of oral exfoliative cytology
.
Cancer Prev Res
.
2010 Apr
;
3
(
4
):
518
28
. .
26.
Rajput
DV
,
Tupkari
JV
.
Early detection of oral cancer: PAP and AgNOR staining in brush biopsies
.
J Oral Maxillofac Pathol
.
2010 Jul
;
14
(
2
):
52
8
. .
27.
Caruntu
ID
,
Scutariu
MM
,
Dobrescu
G
.
Computerized morphometric discrimination between normal and tumoral cells in oral smears
.
J Cell Mol Med
.
2005 Jan‒Mar
;
9
(
1
):
160
8
. .
28.
Bloching
M
,
Hofmann
A
,
Lautenschläger
C
,
Berghaus
A
,
Grummt
T
.
Exfoliative cytology of normal buccal mucosa to predict the relative risk of cancer in the upper aerodigestive tract using the MN-assay
.
Oral Oncol
.
2000 Nov
;
36
(
6
):
550
5
. .
29.
Cankovic
M
,
Ilic
MP
,
Vuckovic
N
,
Bokor-Bratic
M
.
The histological characteristics of clinically normal mucosa adjacent to oral cancer
.
J Cancer Res Ther
.
2013 Apr‒Jun
;
9
(
2
):
240
4
. .
30.
Singam
PK
,
Majumdar
S
,
Uppala
D
,
Kotina
S
,
Namana
M
,
Ayyagari
KR
.
Evaluation of genotoxicity by micronucleus assay in oral leukoplakia and oral squamous cell carcinoma with deleterious habits
.
J Oral Maxillofac Pathol
.
2019 May‒Aug
;
23
(
2
):
300
. .
31.
Remmerbach
TW
,
Weidenbach
H
,
Müller
C
,
Hemprich
A
,
Pomjanski
N
,
Buckstegge
B
,
Diagnostic value of nucleolar organizer regions (AgNORs) in brush biopsies of suspicious lesions of the oral cavity
.
Anal Cell Pathol
.
2003
;
25
(
3
):
139
46
. .
32.
Verma
R
,
Singh
A
,
Badni
M
,
Chandra
A
,
Gupta
S
,
Verma
R
.
Evaluation of exfoliative cytology in the diagnosis of oral premalignant and malignant lesions: a cytomorphometric analysis
.
Dent Res J
.
2015 Jan‒Feb
;
12
(
1
):
83
8
. .
33.
Ogden
GR
,
Cowpe
JG
,
Green
MW
.
Quantitative exfoliative cytology of normal buccal mucosa: effect of smoking
.
J Oral Pathol Med
.
1990 Feb
;
19
(
2
):
53
5
. .
34.
Cancado
RP
,
Yurgel
LS
,
Filho
MS
.
Evaluation of the nucleolar organizer region associated proteins in exfoliative cytology of normal buccal mucosa. Effect of smoking
.
Oral Oncol
.
2001 Jul
;
37
(
5
):
446
54
.
35.
Ramirez
A
,
Saldanha
PH
.
Micronucleus investigation of alcoholic patients with oral carcinomas
.
Genet Mol Res
.
2002 Sep 30
;
1
(
3
):
246
60
.
36.
Schwint
AE
,
Gomez
E
,
Itoiz
ME
,
Cabrini
RL
.
Nucleolar organizer regions as markers of incipient cellular alterations in squamous epithelium
.
J Dent Res
.
1993 Aug
;
72
(
8
):
1233
6
. .
37.
Khandelwal
S
,
Solomon
MC
.
Cytomorphological analysis of keratinocytes in oral smears from tobacco users and oral squamous cell carcinoma lesions: a histochemical approach
.
Int J Oral Sci
.
2010 Mar
;
2
(
1
):
45
52
. .
38.
Ogden
GR
,
Cowpe
JG
,
Green
MW
.
Detection of field change in oral cancer using oral exfoliative cytologic study
.
Cancer
.
1991 Oct 1
;
68
(
7
):
1611
5
. .
39.
Sarode
GS
,
Sarode
SC
,
Maniyar
N
,
Sharma
N
,
Yerwadekar
S
,
Patil
S
.
Recent trends in predictive biomarkers for determining malignant potential of oral potentially malignant disorders
.
Oncol Rev
.
2019 Sep 10
;
13
(
2
):
424
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.